Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change

LA Cysique, D Franklin Jr, I Abramson… - Journal of clinical and …, 2011 - Taylor & Francis
Reliable detection and quantification of longitudinal cognitive change are of considerable
importance in many neurological disorders, particularly to monitor central nervous system …

Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions

EC Caniglia, LE Cain, A Justice, J Tate, R Logan… - Neurology, 2014 - AAN Enterprises
Objective: The link between CNS penetration of antiretrovirals and AIDS-defining neurologic
disorders remains largely unknown. Methods: HIV-infected, antiretroviral therapy–naive …

Randomized trial of central nervous system–targeted antiretrovirals for HIV-associated neurocognitive disorder

RJ Ellis, S Letendre, F Vaida, R Haubrich… - Clinical Infectious …, 2014 - academic.oup.com
Background. Antiretroviral (ARV) medications differentially penetrate across the blood-brain
barrier into central nervous system (CNS) tissues, potentially influencing their effectiveness …

Brain inflammation is a common feature of HIV-infected patients without HIV encephalitis or productive brain infection

E Tavazzi, D Morrison, P Sullivan… - Current HIV …, 2014 - ingentaconnect.com
HIV-associated neurocognitive disorders (HAND) describes different levels of
neurocognitive impairment, which are a common complication of HIV infection. The most …

Neurocognitive impairment and HIV risk factors: a reciprocal relationship

P Anand, SA Springer, MM Copenhaver, FL Altice - AIDS and Behavior, 2010 - Springer
Cognitive impairment among populations at risk for HIV poses a significant barrier to
managing risk behaviors. The impact of HIV and several cofactors, including substance …

Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorder

TM Gates, LA Cysique, KJ Siefried, J Chaganti… - Aids, 2016 - journals.lww.com
Objective: To investigate whether intensification of combined antiretroviral therapy (cART)
with the CC chemokine receptor type 5 (CCR5) entry inhibitor maraviroc leads to …

Structural gray and white matter changes in patients with HIV

M Küper, K Rabe, S Esser, ER Gizewski… - Journal of …, 2011 - Springer
In this cross-sectional study we used magnetic resonance imaging (MRI)-based voxel based
morphometry (VBM) in a sample of HIV positive patients to detect structural gray and white …

Does highly active antiretroviral therapy improve neurocognitive function? A systematic review

JA Joska, H Gouse, RH Paul, DJ Stein… - Journal of …, 2010 - Springer
Highly active antiretroviral therapy (HAART) reduces the incidence of human
immunodeficiency virus (HIV) dementia (HAD), whereas the overall prevalence appears to …

Neurocognitive dysfunction in the highly active antiretroviral therapy era

NZ Mothobi, BJ Brew - Current opinion in infectious diseases, 2012 - journals.lww.com
The prevalence of HAND remains high in the HAART era. Most studies point towards the
benefit of neuro-HAART in the prevention and treatment of HAND. The possible …

Fast implementation for normal mixed effects models with censored response

F Vaida, L Liu - Journal of Computational and Graphical Statistics, 2009 - Taylor & Francis
We propose an EM algorithm for computing the maximum likelihood and restricted maximum
likelihood for linear and nonlinear mixed effects models with censored response. In contrast …